Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M107181200 on September 10, 2001

J. Biol. Chem., Vol. 276, Issue 45, 41930-41937, November 9, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/45/41930    most recent
M107181200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kishore, R.
Right arrow Articles by Nagy, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kishore, R.
Right arrow Articles by Nagy, L. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Stabilization of Tumor Necrosis Factor alpha  mRNA by Chronic Ethanol

ROLE OF A + U-RICH ELEMENTS AND p38 MITOGEN-ACTIVATED PROTEIN KINASE SIGNALING PATHWAY*

Raj Kishore, Megan R. McMullen, and Laura E. NagyDagger

From the Department of Nutrition, Case Western Reserve University, Cleveland, Ohio 44106-4906

Received for publication, July 27, 2001, and in revised form, September 5, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Increased expression of tumor necrosis factor alpha  (TNFalpha ) in response to chronic ethanol has been implicated in the pathogenesis of alcoholic liver disease. However, the molecular mechanisms by which ethanol increases the levels of TNFalpha are not well characterized. Utilizing Kupffer cells isolated from rats fed an ethanol containing diet and a murine macrophage cell line, RAW264.7, exposed to ethanol in culture, we have demonstrated that exposure to chronic ethanol results in an enhanced expression of lipopolysaccharide (LPS)-induced TNFalpha . While chronic ethanol had no effect on the rate of LPS-induced TNFalpha transcription as measured by nuclear run-on experiments, TNFalpha mRNA half-life was increased by chronic ethanol. Chronic ethanol also potentiated the activation of LPS-induced p38 mitogen-activated protein (MAP) kinase in Kupffer cells, as well as in RAW264.7 cells. Specific inhibition of p38 MAP kinase activation by SB203580 in Kupffer cells or by overexpression of dominant negative p38 MAP kinase in RAW264.7 cells blocked ethanol-mediated TNFalpha mRNA stabilization. Furthermore, using chimeric reporter constructs, we have shown that A + U-rich elements in the 3'-untranslated region of TNFalpha mRNA are not sufficient to impart ethanol-mediated stabilization on TNFalpha mRNA.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The inflammatory response is a key component of host defense. Macrophages participate in this tightly regulated process, at least in part, via the secretion of proinflammatory cytokines, such as tumor necrosis factor alpha  (TNFalpha )1 and interleukin-1 (IL-1), in response to various stimuli encountered in the tissue microenvironment. TNFalpha is one of the principal mediators of the inflammatory response in mammals, transducing differential signals that regulate cellular activation and proliferation, cytotoxicity, and apoptosis (1, 2). In addition to its role in acute septic shock, TNFalpha has been implicated in the pathogenesis of a wide variety of inflammatory diseases (3-5) as well as in the progression of alcoholic liver disease (6-9). Data from a number of animal studies, in combination with clinical studies, indicate that long-term alcohol consumption results in the development of fatty liver and steatohepatitis with progression to more severe liver damage including fibrosis, cirrhosis, and hepatocellular carcinoma (9). At least some of these alcohol-induced liver abnormalities have been linked to the overexpression of TNFalpha . Indeed, enhanced levels of TNFalpha have been observed in the liver of ethanol-fed animals, as well as in the circulation of patients with alcoholic liver disease (10, 11). However, the molecular mechanisms leading to this overexpression in response to alcohol are poorly understood.

Considering the pleiotropic actions of TNFalpha , it is not surprising that its biosynthesis is under the control of multiple and complex regulatory mechanisms. TNFalpha expression is regulated at transcriptional, post-transcriptional, as well as translational levels (1, 2, 12). Modulation of mRNA stability is an important mechanism of TNFalpha biosynthesis (12, 13). Stabilization of mRNAs contributes to the strong and rapid induction of genes in the inflammatory process. Although the mechanisms involved in post-transcriptional gene regulation are complex, the mRNA itself contains sequence-specific information that determines its stability (14-16). TNFalpha mRNA, like other short-lived mRNAs, contains A + U-rich elements (ARE) in its 3'-untranslated region (UTR) which function as destabilizing elements as demonstrated in TNFalpha -ARE knockout mouse in vivo (17), as well as in various in vitro systems (13, 18). AREs have also been implicated in stimulus-induced stabilization of otherwise unstable mRNAs (19, 20). Sequences in the 5'-UTRs or coding regions, acting either in concert with AREs in the 3'-UTR or independently, also contribute to mRNA stabilization of certain genes (19, 21). However, the signaling pathways involved in the control of mRNA stabilization are not well defined.

Proinflammatory cytokines and external stressors act through receptor-dependent signaling cascades that diverge into multiple pathways, including the NFkappa B pathway (22) and each of the three mitogen-activated protein (MAP) kinases: extracellular-regulated kinase (ERK), stress-activated protein kinase/c-jun N-terminal kinase (SAPK/JNK), and p38 MAP kinase (23, 24). While each of these signaling pathways contributes to the activation of gene transcription (22, 25), their role in controlling gene expression at the level of mRNA stability is not well understood. Although some studies have shown the involvement of ERK1/2 and SAPK/JNK pathways in the mRNA stability (21, 26-28), the majority of studies suggest that mRNAs encoding for proinflammatory genes including, cyclooxygenase-2 (COX-2), IL-6, IL-8, and TNFalpha , are stabilized upon activation of the p38 MAP kinase pathway (20, 29, 30). This p38 MAP kinase-mediated stabilization is dependent on ARE sequences in the 3'-UTRs of respective genes (20, 29, 31). Thus, while AREs confer instability on mRNAs, they also allow mRNA stabilization following activation of p38 MAPK pathway (30).

Despite the suggested role of TNFalpha in the pathogenesis of alcoholic liver disease, the mechanisms by which chronic alcohol exposure increases TNFalpha expression are not well understood. Ethanol modulates the activity of several important signaling molecules (32) including ERK1/2, p38 MAPK (33), JNK (33, 34), and the transcription factors NFkappa B (35) and Egr-1.2 However, it is not known whether ethanol-induced changes in these pathways contribute to abnormal TNFalpha transcription and/or translation.

To investigate the mechanism for ethanol-mediated increases in TNFalpha , we have studied the effect of chronic ethanol in the regulation of LPS-induced TNFalpha expression, both in Kupffer cells isolated from ethanol-fed rats, as well as in a mouse macrophage like cell line, RAW264.7, exposed to chronic ethanol in culture. We demonstrate, for the first time, that ethanol stabilizes LPS-induced TNFalpha mRNA. We further demonstrate that activation of p38 MAP kinase pathway is required for the ethanol-mediated TNFalpha mRNA stabilization, but that the AREs in the TNFalpha -3'-UTR are not sufficient to mediate ethanol-induced stabilization of TNFalpha mRNA.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents-- Cell culture reagents were from Life Technologies, Inc. (Grand Island, NY). Antibodies were from the following sources: phospho-p38 MAPK, Promega, Madison, WI; and p38 MAPK, Santa Cruz Biotechnology, Santa Cruz, CA; phospho-ERK1/2, Promega; and ERK1/2, Upstate Biotechnology, Lake Placid, NY; anti-rabbit IgG-peroxidase was purchased from Roche Molecular Biochemicals (Indianapolis, IN). PD98059 and SB230580 were from Calbiochem (La Jolla, CA). LPS from Escherichia coli serotype 026:B6 and actinomycin D were purchased from Sigma. Ribonuclease Protection Assay (RPA) kit and reagents were purchased from BD Pharmingen (San Diego, CA) and Ambion (Austin, TX). Sequagel and related buffers were from National Diagnostics (Atlanta, GA). PerkinElmer Life Sciences (Boston, MA) was the source for [alpha -32P]UTP. Transfast transfection reagent and pSP-Luc+ vector used as DNA template for Luciferase RPA probe were purchased from Promega.

Constructs-- Kinase-dead dominant negative constructs for p38, ERK1, and ERK2 MAP kinases were a kind gift from Dr. R. L. Eckert and have been described before (36). Chimeric luciferase-TNF3'UTR constructs (98-18 luciferase-TNF3'UTR and 98-19 luciferase-TNF-ARE mutant) were kindly provided by Dr. V Kruys.

Animals and Chronic Ethanol Feeding Protocol-- Adult male Wistar rats weighing 150 g were purchased from Harlan Sprague-Dawley, Inc. (Indianapolis, IN). Lieber DeCarli ethanol diet was purchased from Dyets (Bethlehem, PA). Rats were acclimatized for 3 days after arrival and provided with free access to Purina rat chow and water. All rats were then allowed free access to liquid diet (37) without ethanol for 2 days and then randomly assigned to the ethanol-fed or pair-fed groups. The ethanol-fed group was allowed free access to liquid diet with 17% of calories as ethanol for 2 days and then provided with diet containing 35% of calories from ethanol for the remainder of the feeding period. Controls were pair-fed a liquid diet that was identical to the ethanol diet except that maltose dextrins were isocalorically substituted for ethanol. Pair-fed rats were given the same amount of food as their ethanol pair consumed in the preceding 24 h. Procedures involving animals were approved by the Institutional Animal Care Board at Case Western Reserve University.

Kupffer Cell Isolation and Cell Culture-- Kupffer cells were isolated as previously described (38) except that CMRL media was used to isolate and culture Kupffer cells. Briefly, livers were perfused with 0.05% collagenase and the resulting suspension of liver cells treated with 0.02% Pronase for 15 min at 12 °C. The resulting cell suspension was centrifuged 3 times at 50 × g for 2 min and the supernatant collected after each centrifugation. The pooled supernatant was then centrifuged at 500 × g for 7 min to collect nonparenchymal cells. Kupffer cells were then purified by centrifugal elutriation (38). The yield and purity of isolated Kupffer cells did not differ between pair-fed and ethanol-fed rats (38). Isolated Kupffer cells were suspended in CMRL with 10% fetal bovine serum and penicillin-streptomycin at a concentration of 2 × 106 cells/ml and plated onto 96-well (0.2 ml/well) or 100-mm (5 ml/well) culture plates. After 2 h, nonadherent cells were removed by aspiration and fresh media supplied. Assays were carried out after 24 h in culture.

Culture and Transfection of RAW264.7 Cells-- Mouse macrophage-like RAW264.7 cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD). Cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and penicillin-streptomycin at 37 °C in a 5% CO2 atmosphere. For ethanol treatments, cells were incubated with 25 mM ethanol for 48 h; culture dishes were wrapped in parafilm to minimize the evaporation during culture. Culture dishes with untreated cells were also wrapped in parafilm. For transfections, RAW264.7 cells were grown in 100-mm dishes to 60% confluency and were transiently transfected with appropriate control and expression vectors using transfast transfection reagent (Promega), following the manufacturer's instructions. Transfected cells were subcultured, treated, or not with 25 mM ethanol for 48 h; stimulated with LPS (100 ng/ml) and treated or not with actinomycin D according to experimental requirements, before the isolation of protein or RNA.

Nuclear Run-on-- Nuclear run-on experiments to measure nascent RNA transcripts were essentially performed as described elsewhere (39). Briefly, Kupffer cells from ethanol- or pair-fed rats and RAW264.7 cells pretreated or not with 25 mM ethanol for 48 h, were stimulated with 0 or 100 ng/ml LPS. Following stimulation, nuclei were isolated from 1 to 2 × 107 cells/experimental group and were incubated with 2 × reaction buffer (10 mM Tris-Cl, 5 mM MgCl2, 0.3 mM KCl, 10 mM each of ATP, GTP, CTP, 1 mM dithiothreitol) in the presence of [alpha -32P]UTP at 30 °C for 30 min and were further incubated with RNase-free DNase 1 (1 mg/ml) for 5 min at 30 °C and with Proteinase K (20 mg/ml) for an additional 30 min at 42 °C. Labeled RNA was harvested and hybridized with mouse TNFalpha and GAPDH cDNAs (ATCC) immobilized on nitrocellulose filters for 36 h at 65 °C. Membranes were thoroughly washed and processed for autoradiography.

Ribonuclease Protection Assay-- Kupffer cells from ethanol and pair-fed rats were stimulated with 100 ng/ml LPS for 1 h. Total RNA was isolated by Trizol method (Life Technologies, Inc.). For mRNA stability experiments, cells were further cultured in the presence or absence of actinomycin D (5 µg/ml) for the indicated times following LPS treatment before RNA was isolated. For some experiments Kupffer cells were pretreated with either 20 µM SB203580 or 50 µM PD98059 before LPS stimulation and RNA isolation. RAW264.7 cells were cultured in the presence or absence of 25 mM ethanol for 48 h prior to the LPS stimulation and actinomycin D treatment. Rat or mouse cytokine multiprobe DNA templates (Pharmingen) were used to synthesize in vitro transcribed antisense riboprobes and RPAs were carried out following the manufacturer's instructions. Samples were run on 5% sequencing gels, dried, and autoradiographed.

Western Blot Analysis-- Kupffer cells isolated from ethanol- and pair-fed rats were stimulated with 0 or 100 ng/ml LPS for the indicated times, washed twice with cold PBS and lysed directly in 2 × Laemmli buffer. Lysates were passed through a 21-gauge needle to shear DNA, boiled for 10 min, and centrifuged briefly. Samples were separated by 10% SDS-PAGE, transferred to PVDF membranes, and probed with specific phospho-anti-MAP kinase antibodies. The membrane was then stripped and reprobed with the corresponding total anti-MAP kinase antibody as a loading control. Bound antibody was detected by enhanced chemiluminescence (Amersham Pharmacia Biotech, Piscataway, NJ). Immunoreactive protein quantity was assessed by scanning densitometry.

Statistical Analysis-- Because of the limited number of Kupffer cells available from each animal, data from several feeding trials are presented in this paper; each trial consisted of 6 rats per feeding group. Values reported are mean ± S.E. Data were analyzed by Student's t test or general linear models procedure (SAS, Carey, IN), blocking for trial effects if data from more than one trial was used.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Chronic Ethanol Consumption Increases LPS-induced TNFalpha mRNA Levels in Kupffer Cells-- We have previously reported that exposure of RAW264.7 cells to chronic ethanol (25 mM for 48 h) increases the level of LPS-induced TNFalpha mRNA expression.2 To investigate whether chronic ethanol would have a similar effect in vivo, TNFalpha mRNA expression was analyzed in Kupffer cells isolated from pair-fed and ethanol-fed rats. As shown in Fig. 1, chronic ethanol consumption increased LPS-induced TNFalpha mRNA accumulation in Kupffer cells isolated from ethanol-fed rats compared with pair-fed rats. Interestingly, ethanol feeding did not affect LPS-induced expression of other proinflammatory cytokines, including IL-4, IL-5, and IL-6. LPS-induced expression of IL-1beta was, however, reduced in response to chronic ethanol feeding. Taken together these results suggest that chronic ethanol specifically enhances LPS-induced TNFalpha mRNA expression.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   Ethanol feeding increases the level of TNFalpha mRNA in rat Kupffer cells. Kupffer cells isolated from pair- and ethanol-fed rats were cultured for 24 h, followed by stimulation with 0 or 100 ng/ml LPS for 60 min. Total RNA was isolated and analyzed for mRNA levels of indicated cytokines by RNase protection assay. Values for LPS stimulated mRNA quantity are shown as mean ± S.E., n = 5; *, p < 0.05. A representative autoradiograph is shown.

Chronic Ethanol Does Not Affect LPS-induced Transcription of TNFalpha Message-- To investigate whether increased expression of LPS-induced TNFalpha in response to chronic ethanol reflects increased transcription, nuclear run-on experiments were carried out in Kupffer cells and RAW264.7 cells. LPS stimulated de novo TNFalpha transcription was comparable between Kupffer cells from ethanol-fed and pair-fed rats (Fig. 2A). Similarly, prior exposure of RAW264.7 cells to 25 mM ethanol for 48 h had no effect on the rate of LPS-induced TNFalpha transcription compared with control cells (Fig. 2B). These results suggest that chronic ethanol does not increase LPS-induced TNFalpha expression at the level of gene transcription.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 2.   Chronic ethanol exposure has no effect on LPS-induced de novo TNFalpha transcription. Kupffer cells isolated from pair- and ethanol-fed rats (A) or RAW264.7 cells exposed to 25 mM ethanol for 48 h in culture (B) were stimulated with 0 or 100 ng/ml LPS. Nuclei were isolated and were analyzed for de novo transcribed TNFalpha and GAPDH mRNA by nuclear run-on experiments. Similar results were obtained in three separate experiments.

LPS-induced TNFalpha mRNA Is Stabilized by Chronic Ethanol Exposure-- There is ample evidence regarding regulation of TNFalpha expression at the level of mRNA stability. To elucidate whether ethanol-mediated increases in the level of TNFalpha mRNA might reflect an increased half-life of the transcripts, mRNA stability experiments were performed in Kupffer cells and RAW264.7 cells. Kupffer cells from ethanol- and pair-fed rats were stimulated with 0 or 100 ng/ml LPS for 60 min. Cells were further incubated in the presence or absence of actinomycin D for 1-2 h. RNA was harvested and analyzed for TNFalpha mRNA expression (Fig. 3A). Chronic ethanol consumption stabilized LPS-induced TNFalpha mRNA in Kupffer cells isolated from ethanol-fed rats (t1/2 > 100 min), compared with those isolated from pair-fed rats (t1/2 < 40 min). In contrast, the half-life of IL-1beta mRNA was not affected by chronic ethanol in the same experiment (data not shown). A similar effect of chronic ethanol was observed on the TNFalpha mRNA stability in RAW 264.7 cells (Fig. 3B). In control cells, LPS-induced TNFalpha mRNA decayed with an approximate half-life of 35 min. However, treatment of cells with 25 mM ethanol for 48 h not only increased the accumulation of TNFalpha mRNA, but also substantially stabilized the TNFalpha transcript (t1/2 > 100 min). These data clearly demonstrate that exposure to chronic ethanol both in vivo and in vitro results in the marked stabilization of LPS-induced TNFalpha mRNA.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3.   LPS-induced TNFalpha mRNA is stabilized by chronic ethanol. A, Kupffer cells were stimulated or not with 100 ng/ml LPS for 60 min and were further cultured in the presence or absence of 5 µg/ml actinomycin D for indicated times. Total RNA was isolated and 5-10 µg of RNA was analyzed for TNFalpha mRNA expression by RNase protection assay. Values represent mean ± S.E. of TNFalpha mRNA corrected for GAPDH expression in five different experiments. B, RAW264.7 cells cultured with or without 25 mM ethanol for 48 h were analyzed for TNFalpha expression as described above. Values represent mean ± S.E. of remaining TNFalpha mRNA levels at different time points corrected for GAPDH expression in three different experiments.

Ethanol-mediated Stabilization of LPS-induced TNFalpha mRNA Is Gene Specific-- mRNA stability of labile genes can be regulated by ARE sequences in their 3'-UTRs. TNFalpha , like other short-lived cytokine genes, has multiple AREs in its 3'-UTR. To investigate whether exposure to chronic ethanol stabilized other short-lived, ARE-containing cytokine mRNAs, we studied the effect of chronic ethanol on IL-12 p40, IL-1beta , IL-6, and IL-2 mRNA stability. The mRNA decay rate for LPS-induced IL-12 p40, IL-1beta , IL-6 (Fig. 4), and IL-2 (Fig. 3B) was similar in RAW264.7 cells cultured with or without ethanol. These results show that chronic ethanol had no effect on the mRNA stability of the other ARE-containing cytokine mRNAs, suggesting that ethanol specifically targets the stabilization of TNFalpha mRNA.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Ethanol-mediated stabilization of TNFalpha mRNA is gene specific. RAW264.7 cells cultured with or without 25 mM ethanol for 48 h were analyzed for mRNA levels of IL-12 p40, IL-1beta , and IL-6 by RPA as described in the legend to Fig. 3. A representative autoradiograph is shown. Values represent mean ± S.E. of remaining mRNA levels at indicated times corrected for GAPDH expression in three different experiments.

Chronic Ethanol Potentiates LPS-induced Activation of p38 MAP Kinase-- Short- and long-term ethanol exposure modulates agonist-mediated activation of p38, ERK1/2 as well as SAPK/JNK MAP kinases in some cell types (33, 34). We have previously shown that chronic ethanol potentiates the LPS-induced activation of ERK1/2 MAP kinases in RAW264.7 cells.2 Since p38 MAP kinase has been implicated in stabilization of cytokine mRNA, we investigated the effect of chronic ethanol on the activation of p38 MAP kinase. Ethanol potentiated and prolonged the LPS-induced phosphorylation of p38 MAP kinase in Kupffer cells isolated from rats fed ethanol compared with pair-fed (Fig. 5A). A similar increase and prolongation in LPS-induced phosphorylation of p38 MAP kinase was observed in RAW264.7 cells cultured in presence of 25 mM ethanol for 48 h compared to control cells (Fig. 5B).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 5.   Chronic ethanol potentiates LPS-induced phosphorylation of p38 MAP kinase. Kupffer cells isolated from pair- and ethanol-fed rats (A) or RAW264.7 cells exposed to 25 mM ethanol for 48 h in culture (B) were stimulated with 0 or 100 ng/ml LPS for the indicated times. Cells were washed twice in phosphate-buffered saline and were directly lysed in 2 × Laemmli buffer. Samples were analyzed for phoshorylated and total p38 MAP kinase protein levels by Western blot analysis. Representative blots are shown. Values represent mean ± S.E. of five experiments for Kupffer cells and three for RAW264.7 macrophages.

Inhibition of p38 MAP Kinase Specifically Eliminates Ethanol-mediated Stabilization of TNFalpha mRNA-- Activation of p38 and ERK1/2 MAP kinases has been linked to mRNA stabilization of otherwise short-lived cytokine and other immediate early response genes (20). Therefore, we tested whether ethanol-induced potentiation of p38 or ERK1/2 MAP kinases was involved in the stabilization of TNFalpha mRNA observed after chronic ethanol exposure. Kupffer cells isolated from ethanol- and pair-fed rats were pretreated with either 20 µM SB203580 or 50 µM PD98059 followed by stimulation with LPS. After stimulation with LPS, Kupffer cells were further treated or not with actinomycin D. Total RNA from each treatment group was analyzed for TNFalpha mRNA levels (Fig. 6). As observed earlier, TNFalpha mRNA was substantially stabilized in Kupffer cells isolated from ethanol-fed rats. Inhibition of p38 activation completely abrogated ethanol-mediated stabilization of TNFalpha mRNA. In contrast, inhibition of ERK1/2 activation by PD98059 had no effect on ethanol-mediated stabilization of TNFalpha mRNA.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 6.   SB203580 blocks the ethanol-mediated stabilization of TNFalpha mRNA in Kupffer cells. Kupffer cells isolated from pair- and ethanol-fed rats were treated with either 20 mM SB203580 or 50 mM PD98059 for 2 h followed by stimulation with 100 ng/ml LPS. Cells were further cultured in presence or absence of actinomycin D for 2 h. Total RNA was analyzed for TNFalpha mRNA by RPAs. A representative autoradiograph is shown. Values represent mean ± S.E. of remaining mRNA levels at indicated times corrected for GAPDH expression in two separate experiments.

To further substantiate the role of MAP kinases in ethanol-mediated stabilization of TNFalpha mRNA, we tested the efficacy of p38 and ERK1/2 dominant negative constructs to block the ethanol-mediated TNFalpha mRNA stability. RAW264.7 cells were transfected either with dominant negative p38 or dominant negative ERK1/2 and mRNA stability experiments were carried out as described earlier (Fig. 7). Efficacy of transfections was determined by Western blots. Overexpression of either p38 or ERK1/2 dominant negative constructs completely blocked the phosphorylation of p38 and ERK1/2, respectively (data not shown). Inhibition of either p38 or ERK1/2 activation reduced LPS-induced TNFalpha mRNA expression by ~50% compared with cells transfected with vector alone, likely a result of reduced transcription. Exposure to chronic ethanol stabilized TNFalpha mRNA in RAW264.7 cells transfected with vector alone. However, this stabilization of TNFalpha mRNA was completely blocked in cells transfected with dominant negative p38 MAP kinase. Transfection of dominant negative ERK1/2 MAP kinase had no discernible effect on the ethanol-mediated TNFalpha mRNA stabilization. These results demonstrate specificity of p38 MAP kinase activation in ethanol-mediated stabilization of TNFalpha mRNA.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 7.   p38 dominant negative overexpression specifically abrogates chronic ethanol-mediated TNFalpha mRNA stability. RAW264.7 cells were transiently transfected either with empty vector or with p38 dominant negative and ERK1/2 dominant negative expression vectors. Transfected cells were subcultured in the presence or absence of 25 mM ethanol for 48 h, stimulated with 100 ng/ml LPS, and further treated or not with actinomycin D for 2 h. RNA was harvested and was analyzed for TNFalpha mRNA expression. Values represent mean ± S.E. of remaining TNFalpha mRNA at indicated times corrected for GAPDH expression in two different experiments. A representative autoradiograph is shown.

ARE Sequences in TNFalpha -3'-UTR Are Not Sufficient to Impart Ethanol-mediated Stabilization on the TNFalpha mRNA-- Since ARE sequences have previously been shown to be an important determinant of TNFalpha mRNA stability, we next determined the role of TNFalpha -ARE sequences in ethanol-mediated stabilization of the TNFalpha transcript. RAW264.7 cells were transiently transfected either with a reporter construct containing full-length 3'-UTR of TNFalpha linked to luciferase reporter gene (pGL3-TNF3'UTR) or a similar chimera in which the 70-nucleotide ARE-containing sequence from TNFalpha 3'-UTR was deleted (pGL3-TNF AUmut). A vector containing luciferase reporter alone was used as a control. Following transfections, cells were either treated or not with 25 mM ethanol for 48 h, stimulated with 100 ng/ml LPS and further cultured in the presence or absence of actinomycin D. Expression of luciferase mRNA was measured by RPA utilizing antisense luciferase or beta -actin riboprobes (Fig. 8). Control luciferase mRNA decayed with a half-life of more than 75 min and was insensitive to ethanol treatment. Inclusion of TNFalpha -3'-UTR sequences had a marked destabilizing effect on the luciferase transgene (t1/2 < 40 min). However, there was no change in the stability of luciferase mRNA when pGL3-TNF3'UTR transfected RAW264.7 cells were exposed to chronic ethanol. Transfection of pGL3-TNF AUmut construct overcame the destabilizing effect of full-length TNFalpha 3'UTR. This construct was also insensitive to ethanol. Taken together, these data suggest that ARE sequences in the 3'-UTR of TNFalpha mRNA, though sufficient to destabilize luciferase mRNA, are not sufficient to impart ethanol-mediated stabilization on the transgene.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 8.   Ethanol-induced stabilization of TNFalpha mRNA is not mediated by AU rich elements. RAW264.7 cells were transiently transfected either with control luciferase vector or with pGL3-TNF3'UTR or pGL3-TNF AUmut vectors. Transfected cells were subcultured in the presence or absence of 25 mM ethanol for 48 h, stimulated with 100 ng/ml LPS, and further treated or not with actinomycin D for 2 h. RNA was harvested and was analyzed for luciferase and beta -actin mRNA levels. Autoradiograph is representative of three similar experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Although enhanced expression of TNFalpha has been implicated in the pathogenesis of alcoholic liver disease, the molecular mechanisms regulating TNFalpha overexpression are not well understood. In the present study, utilizing an ethanol-fed rat model, as well as mouse macrophage cells exposed to ethanol in culture, we have demonstrated that chronic ethanol specifically increases the LPS-induced TNFalpha mRNA stability. Furthermore, stabilization of TNFalpha mRNA by ethanol was dependent on activation of p38 MAP kinase, but independent of the ARE sequences in the 3'-UTR of the TNFalpha mRNA. Chronic ethanol specifically enhanced the accumulation of TNFalpha ; this specific increase in TNFalpha mRNA level was observed both in mouse RAW264.7 macrophage cells after in vitro exposure to ethanol and in Kupffer cells isolated from rats fed ethanol in vivo. Furthermore, in both types of macrophages, chronic ethanol increased the half-life of LPS-induced TNFalpha mRNA, without affecting the rate of TNFalpha transcription. Increased stability of TNFalpha mRNA was directly associated with an increase in LPS-induced activation of p38 MAP kinase; inhibition of p38 MAP kinase activation by two different approaches blocked the ethanol-mediated stabilization of TNFalpha mRNA, while inhibition of ERK1/2 activation did not affect TNFalpha mRNA stability. Moreover, AREs in the 3'-UTR of TNFalpha mRNA destabilized luciferase reporter mRNA but were not sufficient to render ethanol-mediated stabilization on the transgene.

There is now general agreement that long-term alcohol consumption leads to an increased expression of TNFalpha in liver. It has been suggested that chronic ethanol consumption compromises the barrier function of gastrointestinal mucosa, overexposing liver cells to endotoxins, such as LPS, and resulting in an increased TNFalpha production (40-42). Indeed, ethanol-induced liver injury was blunted by treating ethanol-fed rats with antibiotics, further supporting the association of endotoxins with the ethanol-induced liver injury (43). However, little is known about the mechanism by which chronic ethanol up-regulates LPS-induced expression of proinflammatory mediators including TNFalpha . Our data show that ethanol specifically enhanced TNFalpha mRNA level in rat Kupffer cells, but did not increase the accumulation of other proinflammatory cytokines (Fig. 1). Interestingly, chronic ethanol decreased the LPS-induced mRNA accumulation of IL-1beta . IL-1beta expression is regulated by many of the mechanisms as TNFalpha , involving modulation of gene transcription, mRNA stability and mRNA translation (44, 45). Thus, the differential effect of chronic ethanol on LPS-induced mRNA expression of TNFalpha and IL-1beta in Kupffer cells suggests that chronic ethanol must impact on distinct molecular mechanisms and signaling pathways to differentially regulate the expression of TNFalpha compared with IL-1beta .

Cell type and stimulus specific transcriptional regulation of TNFalpha has been reported in a number of studies (1, 2, 46). We have recently demonstrated that exposure of RAW264.7 macrophages to chronic ethanol modulates the LPS-induced DNA binding activity of at least two transcription factors to the TNFalpha promoter. Chronic ethanol increases Egr-1 binding activity, but decreases the binding activity of NFkappa B.2 However, in the present study, we found no discernible changes in the rate of de novo transcribed TNFalpha in response to chronic ethanol (Fig. 2). These results indicate that despite multiple effects on DNA binding activity of key transcription factors, there is no net effect on the rate of TNFalpha transcription in response to chronic ethanol and that post-transcriptional mechanism(s) must contribute to ethanol-mediated up-regulation of TNFalpha mRNA.

Chronic ethanol stabilized the LPS-induced TNFalpha mRNA both in a mouse macrophage cell line RAW264.7 and in Kupffer cells isolated from rats fed ethanol for 4 weeks (Fig. 3). Utilizing a wide variety of cell types, several studies have shown stimulus-specific stabilization of otherwise labile mRNAs that contributes to a rapid increase in their abundance. Phorbol ester treatment increases the half-life of granulocyte macrophage-colony stimulating factor mRNA (16, 47). Calcium ionophore transiently stabilizes IL-3 mRNA in a murine mast cell line (48). In T cells, IL-2 mRNA is stabilized by co-stimulatory signal through CD-28, upon stimulation of T cell receptor (49). More recently a number of studies have shown the stimulus-induced stabilization of COX-2, IL-6, IL-8, GROalpha , MCP-1, and TNFalpha mRNAs in macrophage/monocytes, as well as in other cell types (19, 20, 28, 29, 31, 50). However, this is the first study to demonstrate ethanol-mediated modulation of TNFalpha stability in any cell type. Whether this phenomenon is a more generalized effect of ethanol or is restricted to macrophages remains to be elucidated.

LPS is known to activate all members of the MAP kinase family. To gain insight into the role of MAP kinase signaling pathways in the ethanol-mediated stabilization of TNFalpha transcript, we studied the effect of chronic ethanol on the LPS-induced phosphorylation of p38 and ERK1/2 MAP kinases. Chronic ethanol exposure increased LPS stimulated phosphorylation of p38 MAP kinase (Fig. 5). This observation is consistent with a number of other studies reporting the effect of ethanol on MAP kinase activation. Ethanol exposure, both long- and short-term, potentiates agonist-induced activation of p38, ERK1/2, as well as SAPK/JNK MAP kinases in hepatocytes (33, 34). Long-term ethanol exposure increases NGF-stimulated ERK1/2 in PC12 cells (41). In NIH 3T3 fibroblasts, ethanol potentiates sphingosine-1 phosphate-stimulated ERK1/2 activation, but not p38 MAP kinase (51). More recently we have shown that in RAW264.7 mouse macrophage cells, chronic ethanol increases LPS-stimulated phosphorylation of ERK1/2 MAP kinases.2 The mechanism by which ethanol potentiates LPS-stimulated activation of p38 remains an unresolved question. Since chronic ethanol increases both LPS-stimulated ERK1/2 and p38, we are currently investigating whether ethanol acts at a common upstream signaling intermediate linking LPS-receptor activation to both these members of the MAP kinase family. Alternatively, ethanol could also enhance ERK1/2 and p38 activity by decreasing MAP kinase phosphatase-1 activity, which can inactivate both phosphorylated ERK1/2 and p38.

There is growing body of evidence indicating the participation of MAP kinases in stimulus-induced stabilization of various short-lived transcripts. Studies on the signaling pathways involved in mRNA stability have shown p38, ERK1/2, SAPK/JNK MAP kinases, as well as cAMP-dependent protein kinase A, are important contributors to this post-transcriptional regulatory mechanism (21, 28, 52). The emerging picture from these studies suggests that stabilization of mRNAs can be achieved by different signaling events; effectors of multiple signaling cascades impact on the pathways regulating mRNA decay. These effectors can, therefore, connect changes in the extracellular environment to the post-transcriptional control of gene expression. Here we have shown that inhibition of p38 MAP kinase specifically abrogates the ethanol-mediated stabilization of the TNFalpha transcript (Figs. 6 and 7). p38 MAP kinase has been implicated in the regulation of mRNA stability in other systems as well. For example, while maximal IL-8 gene expression requires activation of all three MAP kinases, the p38 MAP kinase pathway selectively stabilizes IL-8 mRNA (44). Similarly, COX-2 mRNA stabilization in HeLa cells involves activation of p38 MAP kinase (31). Stimulus-induced stabilization of mRNAs encoding for COX-2 (30, 53, 54), IL-6 (20), platelet-derived growth factor receptor alpha  (55), MCP-1 (50), erythropoetin (56), GROalpha , IL-1beta (48), and TNFalpha (29) is mediated via activation of the p38 MAP kinase. The ERK1/2 and SAPK/JNK pathways have also been shown to participate in mRNA stabilization (21, 26-28). Although chronic ethanol potentiates LPS-induced ERK1/2 phosphorylation in RAW264.7 cells,2 inhibition of ERK1/2 activation either by the specific inhibitor PD98059 or by kinase-dead dominant negative ERK1/2 has no effect on stability of TNFalpha mRNA (Figs. 6 and 7). Taken together, our data clearly show that although ethanol can potentiate the LPS-induced activation of both p38 and ERK1/2 MAP kinases, only p38 MAP kinase participates in ethanol-mediated stabilization of the TNFalpha mRNA.

AREs present in the 3'-UTR of cytokine genes are well documented to mediate destabilization and/or stimulus-dependent stabilization of their respective mRNAs (14-16). In most systems studied to date, AREs in the 3'-UTR of corresponding genes mediate stimulus-induced stabilization of the transcripts via p38 MAP kinase pathway (29, 31, 54, 57). Activation of the p38 MAP kinase stabilizes reporter beta -globin mRNAs containing ARE sequences in the 3'-UTRs of IL-6, IL-8, c-fos, and granulocyte macrophage-colony stimulating factor, respectively (20). Therefore, we studied the requirement of the TNFalpha ARE sequences in the destabilization and ethanol-mediated stabilization of reporter luciferase mRNA. As expected, the TNFalpha AREs destabilized reporter mRNA. We, however, saw no evidence that TNFalpha AREs are involved in ethanol-mediated stabilization of the reporter luciferase mRNA. Although data presented in this study do not rule out the necessity of TNFalpha ARE sequences, nevertheless, they indicate that the TNFalpha AREs are not sufficient to modulate ethanol-mediated stabilization of the transcript. There are other examples where regulation of mRNA stability is determined not only by the ARE sequences in the 3'-UTR, but also by additional sequences found either in 5'-UTR or within the coding region of the corresponding mRNA. IL-1beta -induced stabilization of mouse GROalpha in several cell types is determined by sequences both in the 5' and 3'-UTRs (50). Similarly, stabilization of IL-2 mRNA requires sequences in 5'-UTR and the coding regions (21). Whether sequences in the 5'-UTR or the coding region of TNFalpha mRNA are required for ethanol-mediated stabilization of TNFalpha mRNA seen in the present study remains to be determined. After the cis-acting regions conveying ethanol-induced mRNA stability are identified, it also remains to be elucidated which trans-acting factors/proteins and/or additional signal transduction pathways are involved in chronic ethanol-modulated mRNA stability. One potentially important target of ethanol-mediated mRNA stability is the protein kinase C (PKC) pathway. Ethanol is known to regulate PKC activity in many cell types; the delta  and epsilon  isoforms are particularly sensitive to ethanol (32). PKC-mediated mRNA stabilization has been reported in a number of studies (58-60); PKCdelta has been specifically implicated in regulation of iNOS mRNA stability (61). While PKC is involved in many LPS-mediated responses in macrophages (62), we are currently investigating whether a specific PKC isoform is involved in TNFalpha mRNA stability and if that isoform is targeted by chronic ethanol exposure.

Considering the association between ethanol-mediated up-regulation in TNFalpha expression and alcoholic liver disease, it is critical to understand the mechanism by which ethanol increases TNFalpha biosynthesis. Our data provide direct evidence for a novel mechanism for ethanol-mediated up-regulation of TNFalpha biosynthesis. While other studies have demonstrated that ethanol increases TNFalpha mRNA expression, this is the first study to demonstrate that chronic ethanol, signaling selectively through the p38 MAP kinase pathway, enhances the LPS-induced TNFalpha expression by stabilizing the TNFalpha transcript. Moreover, our data demonstrate that ethanol specifically enhances TNFalpha mRNA stability. Therefore, this response is likely to contribute to the critical role that TNFalpha plays in the progression of inflammation during alcoholic liver disease.

    ACKNOWLEDGEMENTS

We are thankful to Dr. R. L. Eckert, Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, for providing p38, ERK1, and ERK2 dominant negative expression vectors. We are also thankful to Dr. V. Kruys, Laboratory of Chemical Biology, Universite Libre de Bruxelles, Gosselies, Belgium, for kindly providing reporter luciferase-TNFalpha constructs.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant AA 11975 (to L. E. N.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Nutrition, 2123 Abington Rd., Rm. 201, Case Western Reserve University, Cleveland, OH 44106-4906. Tel.: 216-368-6230; Fax: 216-368-6644; E-mail: len2@po.cwru.edu.

Published, JBC Papers in Press, September 10, 2001, DOI 10.1074/jbc.M107181200

2 L. Shi, R. Kishore, M. R. McMullen, and L. E. Nagy, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: TNFalpha , tumor necrosis factor alpha ; IL, interleukin; LPS, lipopolysaccharide; RPA, RNase protection assay; MAP, mitogen-activated protein; ERK, extracellular regulated kinase; SAPK/JNK, stress activated protein kinase/c-Jun N-terminal kinase; UTR, untranslated region; ARE, A + U-rich elements; COX-2, cyclo-oxygenase-2; PKC, protein kinase C; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Beutler, B. (1995) J. Invest. Med. 43, 227-235[Medline] [Order article via Infotrieve]
2. Jacob, C. O. (1992) Immunol. Today 13, 122-125[CrossRef][Medline] [Order article via Infotrieve]
3. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., and Kollias, G. (1991) EMBO J. 10, 4025-4031[Medline] [Order article via Infotrieve]
4. Reimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Baumann, R., Poindron, P., and Duclos, B. (1996) J. Clin. Immunol. 16, 144-150[CrossRef][Medline] [Order article via Infotrieve]
5. Shalaby, M. R., Fendly, B., Sheehan, K. C., Schreiber, R. D., and Ammann, A. J. (1989) Transplantation 47, 1057-1061[Medline] [Order article via Infotrieve]
6. Akerman, P., Cote, P., Yang, S. Q., McClain, C., Nelson, S., Bagby, G. J., and Diehl, A. M. (1992) Am. J. Physiol. 263, G579-585[Abstract/Free Full Text]
7. Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., and Taub, R. (1996) Science 274, 1379-1383[Abstract/Free Full Text]
8. Thurman, R. G. (1998) Am. J. Physiol. 275, G605-G611[Abstract/Free Full Text]
9. Tilg, H., and Diehl, A. M. (2000) N. Engl. J. Med. 343, 1467-1476[Free Full Text]
10. Bode, C., Kugler, V., and Bode, J. C. (1987) J. Hepatol. 4, 8-14[CrossRef][Medline] [Order article via Infotrieve]
11. Fukui, H., Brauner, B., Bode, J., and Bode, C. (1991) J. Hepatol. 12, 162-169[CrossRef][Medline] [Order article via Infotrieve]
12. Jacob, C. O., Lee, S. K., and Strassmann, G. (1996) J. Immunol. 156, 3043-3050[Abstract]
13. Hel, Z., Skamene, E., and Radzioch, D. (1996) Mol. Cell. Biol. 16, 5579-5590[Abstract]
14. Sachs, A. B. (1993) Cell 74, 413-421[CrossRef][Medline] [Order article via Infotrieve]
15. Ross, J. (1995) Microbiol. Rev. 59, 423-450[Abstract/Free Full Text]
16. Shaw, G., and Kamen, R. (1986) Cell 46, 659-667[CrossRef][Medline] [Order article via Infotrieve]
17. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F., and Kollias, G. (1999) Immunity 10, 387-398[CrossRef][Medline] [Order article via Infotrieve]
18. Lagnado, C. A., Brown, C. Y., and Goodall, G. J. (1994) Mol. Cell. Biol. 14, 7984-7995[Abstract/Free Full Text]
19. Tebo, J. M., Datta, S., Kishore, R., Kolosov, M., Major, J. A., Ohmori, Y., and Hamilton, T. A. (2000) J. Biol. Chem. 275, 12987-12993[Abstract/Free Full Text]
20. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C. Y., Shyu, A. B., Muller, M., Gaestel, M., Resch, K., and Holtmann, H. (1999) EMBO J. 18, 4969-4980[CrossRef][Medline] [Order article via Infotrieve]
21. Chen, C. Y., Del Gatto-Konczak, F., Wu, Z., and Karin, M. (1998) Science 280, 1945-1949[Abstract/Free Full Text]
22. Baldwin, A. S., Jr. (1996) Annu. Rev. Immunol. 14, 649-683[CrossRef][Medline] [Order article via Infotrieve]
23. Karin, M. (1998) Ann. N. Y. Acad. Sci. 851, 139-146[CrossRef][Medline] [Order article via Infotrieve]
24. Widmann, C., Gibson, S., Jarpe, M. B., and Johnson, G. L. (1999) Physiol. Rev. 79, 143-180[Abstract/Free Full Text]
25. Karin, M., Liu, Z., and Zandi, E. (1997) Curr. Opin. Cell Biol. 9, 240-246[CrossRef][Medline] [Order article via Infotrieve]
26. Lee, N. H., and Malek, R. L. (1998) J. Biol. Chem. 273, 22317-22325[Abstract/Free Full Text]
27. Ming, X. F., Kaiser, M., and Moroni, C. (1998) EMBO J. 17, 6039-6048[CrossRef][Medline] [Order article via Infotrieve]
28. Xu, K., Robida, A. M., and Murphy, T. J. (2000) J. Biol. Chem. 275, 23012-23019[Abstract/Free Full Text]
29. Brook, M., Sully, G., Clark, A. R., and Saklatvala, J. (2000) FEBS Lett. 483, 57-61[CrossRef][Medline] [Order article via Infotrieve]
30. Dean, J. L., Wait, R., Mahtani, K. R., Sully, G., Clark, A. R., and Saklatvala, J. (2001) Mol. Cell. Biol. 21, 721-730[Abstract/Free Full Text]
31. Lasa, M., Brook, M., Saklatvala, J., and Clark, A. R. (2001) Mol. Cell. Biol. 21, 771-780[Abstract/Free Full Text]
32. Diamond, I., and Gordon, A. S. (1997) Physiol. Rev. 77, 1-20[Abstract/Free Full Text]
33. Chen, J. P., Ishac, E. J. N., Dent, P., Kunos, G., and Gao, B. (1998) Biochem. J. 334, 669-676
34. Roivainen, R., Hundle, B., and Messing, R. O. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1891-1895[Abstract/Free Full Text]
35. Zeldin, G., Yang, S. Q., Yin, M., Lin, H. Z., Rai, R., and Diehl, A. M. (1996) Alcohol. Clin. Exp. Res. 20, 1639-1645[CrossRef][Medline] [Order article via Infotrieve]
36. Efimova, T., LaCelle, P., Welter, J. F., and Eckert, R. L. (1998) J. Biol. Chem. 273, 24387-24395[Abstract/Free Full Text]
37. Lieber, C. S., and DeCarli, L. M. (1982) Alcohol. Clin. Exp. Res. 6, 523-531[Medline] [Order article via Infotrieve]
38. Aldred, A., and Nagy, L. E. (1999) Am. J. Physiol. 276, G98-G106[Abstract/Free Full Text]
39. Greenberg, M. E., and Ziff, E. B. (1984) Nature 311, 433-438[CrossRef][Medline] [Order article via Infotrieve]
40. Bickel, M., Cohen, R. B., and Pluznik, D. H. (1990) J. Immunol. 145, 840-845[Abstract]
41. Honchel, R., Marsono, L., Cohen, D., Shedlofsky, S., and McClain, C. (1990) in The Physiological and Pathological Effects of Cytokines (Dinarello, C. A. , Kluger, M. J. , Powanda, M. C. , and Oppenheim, J. J., eds), Vol. 10B , pp. 171-176, Wiley-Liss, New York
42. Mathurin, P., Deng, Q. G., Keshavarzian, A., Choudhary, S., Holmes, E. W., and Tsukamoto, H. (2000) Hepatology 32, 1008-1017[CrossRef][Medline] [Order article via Infotrieve]
43. Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W., and Thurman, R. G. (1995) Gastroenterology 108, 218-224[CrossRef][Medline] [Order article via Infotrieve]
44. Holtmann, H., Winzen, R., Holland, P., Eickemeier, S., Hoffmann, E., Wallach, D., Malinin, N. L., Cooper, J. A., Resch, K., and Kracht, M. (1999) Mol. Cell. Biol. 19, 6742-6753[Abstract/Free Full Text]
45. Saklatvala, J., Dean, J., and Finch, A. (1999) Biochem. Soc. Symp. 64, 63-77[Medline] [Order article via Infotrieve]
46. Pauli, U. (1994) Crit. Rev. Eukaryotic Gene Exp. 4, 323-344[Medline] [Order article via Infotrieve]
47. Bjarnason, I., Ward, K., and Peters, T. J. (1984) Lancet 1, 179-182[Medline] [Order article via Infotrieve]
48. Wodnar-Filipowicz, A., and Moroni, C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 777-781[Abstract/Free Full Text]
49. Lindstein, T., June, C. H., Ledbetter, J. A., Stella, G., and Thompson, C. B. (1989) Science 244, 339-343[Abstract/Free Full Text]
50. Rovin, B. H., Wilmer, W. A., Danne, M., Dickerson, J. A., Dixon, C. L., and Lu, L. (1999) Cytokine 11, 118-126[CrossRef][Medline] [Order article via Infotrieve]
51. Huang, J. S., Mukherjee, J. J., and Kiss, Z. (1999) Arch. Biochem. Biophys. 366, 131-138[CrossRef][Medline] [Order article via Infotrieve]
52. Xu, K., and Murphy, T. J. (2000) J. Biol. Chem. 275, 7604-7611[Abstract/Free Full Text]
53. Jang, B. C., Sanchez, T., Schaefers, H. J., Trifan, O. C., Liu, C. H., Creminon, C., Huang, C. K., and Hla, T. (2000) J. Biol. Chem. 275, 39507-39515[Abstract/Free Full Text]
54. Ridley, S. H., Dean, J. L., Sarsfield, S. J., Brook, M., Clark, A. R., and Saklatvala, J. (1998) FEBS Lett. 439, 75-80[CrossRef][Medline] [Order article via Infotrieve]
55. Wang, Y. Z., Zhang, P., Rice, A. B., and Bonner, J. C. (2000) J. Biol. Chem. 275, 22550-22557[Abstract/Free Full Text]
56. Tamura, K., Sudo, T., Senftleben, U., Dadak, A. M., Johnson, R., and Karin, M. (2000) Cell 102, 221-231[CrossRef][Medline] [Order article via Infotrieve]
57. Sirenko, O. I., Lofquist, A. K., DeMaria, C. T., Morris, J. S., Brewer, G., and Haskill, J. S. (1997) Mol. Cell. Biol. 17, 3898-3906[Abstract]
58. Hanford, D. S., and Glembotski, C. C. (1996) Mol. Endo. 10, 1719-1727[Abstract/Free Full Text]
59. Nanbu, R., Montero, L., D'Orazio, D., and Nagamine, Y. (1996) Eur. J. Biochem. 247, 169-174[Medline] [Order article via Infotrieve]
60. Short, S., Tian, D., Short, M. L., and Jungmann, R. A. (2000) J. Biol. Chem. 275, 12963-12969[Abstract/Free Full Text]
61. Carpenter, L., Cordery, D., and Biden, T. J. (2001) J. Biol. Chem. 276, 5368-5374[Abstract/Free Full Text]
62. Sweet, M. J., and Hume, D. A. (1996) J. Leukocyte Biol. 60, 8-26[Abstract]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P.-H. Park, H. Huang, M. R. McMullen, P. Mandal, L. Sun, and L. E. Nagy
Suppression of Lipopolysaccharide-stimulated Tumor Necrosis Factor-{alpha} Production by Adiponectin Is Mediated by Transcriptional and Post-transcriptional Mechanisms
J. Biol. Chem., October 3, 2008; 283(40): 26850 - 26858.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Gobejishvili, S. Barve, S. Joshi-Barve, and C. McClain
Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G718 - G724.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Gobejishvili, S. Barve, S. Joshi-Barve, S. Uriarte, Z. Song, and C. McClain
Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-{kappa}B activity and TNF expression: relevance to alcoholic liver disease
Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G681 - G688.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. Rajasingh, E. Bord, C. Luedemann, J. Asai, H. Hamada, T. Thorne, G. Qin, D. Goukassian, Y. Zhu, D. W. Losordo, et al.
IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression
FASEB J, October 1, 2006; 20(12): 2112 - 2114.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Thakur, M. T. Pritchard, M. R. McMullen, Q. Wang, and L. E. Nagy
Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-{alpha} production
J. Leukoc. Biol., June 1, 2006; 79(6): 1348 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. Thakur, M. T. Pritchard, M. R. McMullen, and L. E. Nagy
Adiponectin normalizes LPS-stimulated TNF-{alpha} production by rat Kupffer cells after chronic ethanol feeding
Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G998 - G1007.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
K. I. Happel and S. Nelson
Alcohol, Immunosuppression, and the Lung
Proceedings of the ATS, December 1, 2005; 2(5): 428 - 432.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Cullen, S. Sayeed, Y. Jin, N. G. Theodorakis, J. V. Sitzmann, P. A. Cahill, and E. M. Redmond
Ethanol inhibits monocyte chemotactic protein-1 expression in interleukin-1{beta}-activated human endothelial cells
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1669 - H1675.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. K. Dahle, G. Overland, A. E. Myhre, J. F. Stuestol, T. Hartung, C. D. Krohn, O. Mathiesen, J. E. Wang, and A. O. Aasen
The Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway Is Activated by Lipoteichoic Acid and Plays a Role in Kupffer Cell Production of Interleukin-6 (IL-6) and IL-10
Infect. Immun., October 1, 2004; 72(10): 5704 - 5711.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. Jaruga, F. Hong, W.-H. Kim, R. Sun, S. Fan, and B. Gao
Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol disregulation of NF-{kappa}B and STAT3 signaling pathways
Am J Physiol Gastrointest Liver Physiol, August 1, 2004; 287(2): G471 - G479.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Kishore, C. Luedemann, E. Bord, D. Goukassian, and D. W. Losordo
Tumor Necrosis Factor-Mediated E2F1 Suppression in Endothelial Cells: Differential Requirement of c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Signal Transduction Pathways
Circ. Res., November 14, 2003; 93(10): 932 - 940.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. McMullen, E. Cocuzzi, M. Hatzoglou, and L. E. Nagy
Chronic Ethanol Exposure Increases the Binding of HuR to the TNF{alpha} 3'-Untranslated Region in Macrophages
J. Biol. Chem., October 3, 2003; 278(40): 38333 - 38341.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
L. E. Nagy
Recent Insights into the Role of the Innate Immune System in the Development of Alcoholic Liver Disease
Experimental Biology and Medicine, September 1, 2003; 228(8): 882 - 890.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Enomoto, Y. Takei, M. Hirose, A. Konno, T. Shibuya, S. Matsuyama, S. Suzuki, K. I. T. Kitamura, and N. Sato
Prevention of Ethanol-Induced Liver Injury in Rats by an Agonist of Peroxisome Proliferator-Activated Receptor-{gamma}, Pioglitazone
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 846 - 854.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-J. Zhao, L. Marrero, K. Song, P. Oliver, S. Y. Chin, H. Simon, J. R. Schurr, Z. Zhang, D. Thoppil, S. Lee, et al.
Acute Alcohol Inhibits TNF-{alpha} Processing in Human Monocytes by Inhibiting TNF/TNF-{alpha}-Converting Enzyme Interactions in the Cell Membrane
J. Immunol., March 15, 2003; 170(6): 2923 - 2931.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. K. Koul, M. Menon, L. S. Chaturvedi, S. Koul, A. Sekhon, A. Bhandari, and M. Huang
COM Crystals Activate the p38 Mitogen-activated Protein Kinase Signal Transduction Pathway in Renal Epithelial Cells
J. Biol. Chem., September 20, 2002; 277(39): 36845 - 36852.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Shi, R. Kishore, M. R. McMullen, and L. E. Nagy
Chronic Ethanol Increases Lipopolysaccharide-stimulated Egr-1 Expression in RAW 264.7 Macrophages. CONTRIBUTION TO ENHANCED TUMOR NECROSIS FACTOR alpha PRODUCTION
J. Biol. Chem., April 19, 2002; 277(17): 14777 - 14785.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Shi, R. Kishore, M. R. McMullen, and L. E. Nagy
Lipopolysaccharide stimulation of ERK1/2 increases TNF-alpha production via Egr-1
Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1205 - C1211.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/45/41930    most recent
M107181200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kishore, R.
Right arrow Articles by Nagy, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kishore, R.
Right arrow Articles by Nagy, L. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement